Respiratory arrest in myasthenia gravis with colistimethate therapy.
D000368:Aged; D000667:Ampicillin / Q000008:administration & dosage; D002228:Carbenicillin / Q000008:administration & dosage; D003091:Colistin / Q000009:adverse effects*; D004491:Edrophonium / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008508:Medication Errors; D009157:Myasthenia Gravis / Q000150:complications*; D009388:Neostigmine / Q000008:administration & dosage; D009467:Neuromuscular Depolarizing Agents; D011324:Primidone / Q000009:adverse effects; D011552:Pseudomonas Infections / Q000188:drug therapy; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D012131:Respiratory Insufficiency / Q000139:chemically induced* / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy*
D009467:Neuromuscular Depolarizing Agents; D011324:Primidone; D009388:Neostigmine; D004491:Edrophonium; D000667:Ampicillin; D002228:Carbenicillin; D011729:Pyridostigmine Bromide; D003091:Colistin